This study investigates pancreatic cancer. It examines the effects of panitumumab-IRDye800, which combines an antibody drug with a special dye that can be seen using a camera.
The purpose of this study is to evaluate how well the investigational dye helps in identifying cancer cells during surgery. It also looks at the safety and tolerability of this imaging method.
- Who can participate: Adults with suspected or confirmed pancreatic cancer who plan to have surgery may join. Participants should have a life expectancy of more than 12 weeks and meet specific health criteria.
- Study details: Participants will receive an investigational dye and undergo surgery. The study evaluates how well the dye works during surgery.
How understandable was the trial content above?
Hard to understand
Easy to understand